Sweetgreen, Inc.
SG · NYSE
Analyst ratings
hold · 14 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 27, 2026 | TD Cowen | Maintains | Hold | $8.00 |
| May 22, 2026 | JP Morgan | Upgrades | Overweight | $13.00 |
| May 20, 2026 | Oppenheimer | Maintains | Outperform | $10.00 |
| May 11, 2026 | DA Davidson | Maintains | Neutral | $7.00 |
| May 8, 2026 | UBS | Maintains | Neutral | $7.00 |
| May 8, 2026 | TD Cowen | Maintains | Hold | $7.00 |
| May 8, 2026 | BNP Paribas | Maintains | Underperform | $5.00 |
| March 27, 2026 | Piper Sandler | Maintains | Neutral | $7.00 |
| February 27, 2026 | Citigroup | Maintains | Buy | $9.00 |
| February 27, 2026 | RBC Capital | Maintains | Outperform | $7.00 |
| February 27, 2026 | Oppenheimer | Maintains | Outperform | $9.00 |
| February 23, 2026 | UBS | Maintains | Neutral | $6.50 |
| January 29, 2026 | Goldman Sachs | Maintains | Sell | $5.60 |
| January 20, 2026 | Morgan Stanley | Maintains | Equal-Weight | $9.00 |
| January 20, 2026 | JP Morgan | Maintains | Neutral | $8.00 |
| January 7, 2026 | Barclays | Maintains | Equal-Weight | $7.00 |
| December 17, 2025 | Wells Fargo | Downgrades | Equal-Weight | $7.00 |
| November 10, 2025 | Barclays | Maintains | Equal-Weight | $5.00 |
| November 7, 2025 | RBC Capital | Maintains | Outperform | $7.00 |
| November 7, 2025 | Wells Fargo | Maintains | Overweight | $10.00 |
| November 7, 2025 | Piper Sandler | Maintains | Neutral | $9.00 |
| November 3, 2025 | UBS | Maintains | Buy | $12.00 |
| October 22, 2025 | Barclays | Maintains | Equal-Weight | $8.00 |
| October 16, 2025 | Wells Fargo | Maintains | Overweight | $13.00 |
| October 6, 2025 | B of A Securities | Downgrades | Neutral | $9.50 |
Path to profitability and EPS trajectory
Net loss per share is forecast to shrink dramatically from -$1.14 to -$0.071 next year, and Zacks projects year-over-year EPS improvement of 35% for the next quarter. The consensus estimate calls for full-year earnings of $0.62 per share, representing a +154.39% change, signaling meaningful progress toward profitability.
Despite near-term EPS improvements, the five-year EPS growth forecast remains deeply negative at -24.36%, and the company holds a weak Piotroski F-Score of 3, suggesting that structural financial challenges will persist well beyond any short-term gains.
Valuation and analyst sentiment divergence
Sweetgreen trades at a Forward P/E of 14.6, a notable discount to its industry average of 20.35, with a PEG ratio of 1.19, suggesting the stock may be undervalued. One analyst consensus pegs the average price target at $16.39, implying nearly 194% upside from recent prices.
Analyst consensus has shifted to a 'Hold' rating, with 8 out of 14 analysts taking a negative stance and only 4 remaining optimistic. The current average price target of $7.94 reflects considerably more muted expectations, highlighting deep disagreement about the stock's fair value.
Revenue growth and traffic recovery outlook
Signs of improving customer traffic and a discounted valuation are fueling optimism, with consensus revenue estimates pointing to $708.46 million for the full year, up 4.27% year-over-year. Monthly share price momentum, up 18.34%, further reflects growing investor confidence in a recovery.
Sweetgreen continues to miss earnings estimates, and the five-year revenue growth forecast of only 12.95% raises questions about long-term scalability. High stock price volatility, reflected in a beta of 1.94, and an 86.82% decline over 52 weeks underscore persistent concerns about the company's business model.